Specialty Sales Executive
Current• Circle of Excellence Winner - FY 2018 and FY 2020• Ranked #1 out of 47 – S1 2018 152% to goal• Increased Xiaflex by 36.5% 2018 versus 2017• Sales Ops Task Force 2019Establish new relationships by selling XIAFLEX (collagenase clostridium histolyticum) an orphan drug biologic injectable in the rare disease space to Orthopedic, Hand, and Plastic Surgeons• Promote XIAFLEX, a minimally invasive treatment option for patients with Dupuytren’s Contracture with a palpable cord.• Training physicians and their staff to implement buy and bill and specialty pharmacy into their medical practice • Responsible for the continued growth of XIAFLEX, protecting and growing current customers as well as prospecting and enrolling new injectors.• Work closely on integration of XIAFLEX onto hospital formulary. Required to have expertise with CPT codes, J-Codes, and ICD-10 codes in order to ensure approval of XIAFLEX followed by the proper reimbursement of the medication and procedure codes.